Review

Published on 11 Nov 2022

Review of preclinical data of PF-07304814 and its active metabolite derivatives against SARS-CoV-2 infection

in Pharmacology of Infectious Diseases

Wujun Chen
Yingchun Shao
Xiaojin Peng
Bing Liang
Jiazhen Xu
Dongming Xing

Frontiers in Pharmacology

doi 10.3389/fphar.2022.1035969

3,622 views
6 citations

Opinion

Published on 08 Nov 2022

Emerging pneumonia-like illness “legionellosis” in Argentina in the COVID-19 era: Cause to panic?

in Pharmacology of Infectious Diseases

Ranjan K. Mohapatra
Ahmed Mahal
Venkataramana Kandi
L. V. Simhachalam Kutikuppala
Ashish K. Sarangi
Snehasish Mishra

Frontiers in Pharmacology

doi 10.3389/fphar.2022.1063237

1,422 views

Original Research

Published on 08 Nov 2022

The effect of Nigella sativa and vitamin D3 supplementation on the clinical outcome in COVID-19 patients: A randomized controlled clinical trial

in Pharmacology of Infectious Diseases

Shimaa A. Said
Alsayyed Abdulbaset
Amal A. El-Kholy
Osama Besckales
Nagwa A. Sabri

Frontiers in Pharmacology

doi 10.3389/fphar.2022.1011522

6,931 views
8 citations

Review

Published on 08 Nov 2022

Nanodelivery of antiretroviral drugs to nervous tissues

in Pharmacology of Infectious Diseases

Sodiq Kolawole Lawal
Samuel Oluwaseun Olojede
Oluwaseun Samuel Faborode
Okikioluwa Stephen Aladeyelu
Matome Nadab Matshipi
Sheu Oluwadare Sulaiman
Edwin Coleridge Stephen Naidu
Carmen Olivia Rennie
Onyemaechi Okpara Azu

Frontiers in Pharmacology

doi 10.3389/fphar.2022.1025160

2,798 views
4 citations

Original Research

Published on 03 Nov 2022

The recommended dosage regimen for caspofungin in patients with higher body weight or hypoalbuminaemia will result in low exposure: Five years of data based on a population pharmacokinetic model and Monte-Carlo simulations

in Pharmacology of Infectious Diseases

Qianting Yang
Tao Zhang
Ying Zhang
Dan Sun
Xiaowei Zheng
Qian Du
Xue Wang
Xiaoliang Cheng
Jianfeng Xing
Yalin Dong

Frontiers in Pharmacology

doi 10.3389/fphar.2022.993330

3,521 views
4 citations

Review

Published on 31 Oct 2022

Synthetic approaches to potent heterocyclic inhibitors of tuberculosis: A decade review

in Pharmacology of Infectious Diseases

Upala Dasmahapatra
Kaushik Chanda

Frontiers in Pharmacology

doi 10.3389/fphar.2022.1021216

2,790 views
2 citations

Original Research

Published on 25 Oct 2022

Berberine prevents lethal EV71 neurological infection in newborn mice

in Pharmacology of Infectious Diseases

Guangyi Cui
Han Wang
Chongting Yang
Xiaoxiao Zhou
Junyi Wang
Tong Wang
Tonghui Ma

Frontiers in Pharmacology

doi 10.3389/fphar.2022.1027566

2,877 views
9 citations

Review

Published on 21 Oct 2022

Polyphenolic promiscuity, inflammation-coupled selectivity: Whether PAINs filters mask an antiviral asset

in Pharmacology of Infectious Diseases

Rick Sheridan
Kevin Spelman

Frontiers in Pharmacology

doi 10.3389/fphar.2022.909945

3,249 views
9 citations

Original Research

Published on 20 Oct 2022

Genotype-phenotype association and biochemical analyses of glucose-6-phosphate dehydrogenase variants: Implications for the hemolytic risk of using 8-aminoquinolines for radical cure

in Pharmacology of Infectious Diseases

Sirapapha Sudsumrit
Kamonwan Chamchoy
Duantida Songdej
Poom Adisakwattana
Srivicha Krudsood
Emily R. Adams
Mallika Imwong
Ubolsree Leartsakulpanich
Usa Boonyuen

Frontiers in Pharmacology

doi 10.3389/fphar.2022.1032938

2,273 views
3 citations

Original Research

Published on 18 Oct 2022

Minocycline intra-bacterial pharmacokinetic hysteresis as a basis for pharmacologic memory and a backbone for once-a-week pan-tuberculosis therapy

in Pharmacology of Infectious Diseases

Devyani Deshpande
Shashikant Srivastava
Jotam Garaimunashe Pasipanodya
Tawanda Gumbo

Frontiers in Pharmacology

doi 10.3389/fphar.2022.1024608

1,885 views

Original Research

Published on 14 Oct 2022

Safety and effectiveness of all-oral and injectable-containing, bedaquiline-based long treatment regimen for pre-XDR tuberculosis in Vietnam

in Pharmacology of Infectious Diseases

Thi Mai Phuong Nguyen
Binh Hoa Nguyen
Thi Thanh Thuy Hoang
Hoang Anh Nguyen
Dinh Hoa Vu
Mai Hoa Nguyen
Bao Ngoc Nguyen
Tom Decroo
Viet Nhung Nguyen

Frontiers in Pharmacology

doi 10.3389/fphar.2022.1023704

2,383 views
3 citations

Brief Research Report

Published on 14 Oct 2022

Antimicrobial and anti-inflammatory effects of Eugenia brejoensis essential oil in mice wounds infected by Staphylococcus aureus

in Pharmacology of Infectious Diseases

Roseana Muniz Diniz
Tatiany Gomes Ferreira Fernandes
Juliana Silva Pereira Mendonça
Lucas dos Santos Silva
Warlison Felipe de Silva Saminez
Patrícia Vieira de Oliveira
Erika Alves Da Fonseca Amorim
Cristiane Santos Silva e Silva Figueiredo
Clovis Macêdo Bezerra Filho
Maria Tereza dos Santos Correia

Frontiers in Pharmacology

doi 10.3389/fphar.2022.999131

2,141 views
5 citations

Systematic Review

Published on 13 Oct 2022

Terpenes as bacterial efflux pump inhibitors: A systematic review

in Pharmacology of Infectious Diseases

Kaio Jefté Santos De Oliveira Dias
Gustavo Marinho Miranda
Jonatas Reis Bessa
Ana Carolina Justino De Araújo
Priscilla Ramos Freitas
Ray Silva De Almeida
Cícera Laura Roque Paulo
José Bezerra De Araújo Neto
Henrique D. M. Coutinho
Jaime Ribeiro-Filho

Frontiers in Pharmacology

doi 10.3389/fphar.2022.953982

7,328 views
20 citations

Original Research

Published on 10 Oct 2022

The OBTAINS study: A nationwide cross-sectional survey on the implementation of extended or continuous infusion of β-lactams and vancomycin among neonatal sepsis patients in China

in Pharmacology of Infectious Diseases

Pengxiang Zhou
Yinchu Cheng
Guangna Cao
Yan Xing
Suodi Zhai
Xiaomei Tong
Kehu Yang

Frontiers in Pharmacology

doi 10.3389/fphar.2022.1001924

1,992 views
2 citations

Systematic Review

Published on 06 Oct 2022

Effects of CYP2C19 genetic polymorphisms on the cure rates of H. pylori in patients treated with the proton pump inhibitors: An updated meta-analysis

in Pharmacology of Infectious Diseases

Xianghong Zhao
Zhongqiu Zhang
Fang Lu
Mengqiu Xiong
Liping Jiang
Ke Tang
Min Fu
Yu Wu
Bangshun He

Frontiers in Pharmacology

doi 10.3389/fphar.2022.938419

3,452 views
7 citations

Editorial

Published on 06 Oct 2022

Editorial: Women in pharmacology of infectious diseases: 2021

in Pharmacology of Infectious Diseases

Elena K. Schneider-Futschik
Isabel Spriet
Hong Zhou

Frontiers in Pharmacology

doi 10.3389/fphar.2022.1038369

1,010 views

Navigation group

Articles

Review of preclinical data of PF-07304814 and its active metabolite derivatives against SARS-CoV-2 infection

Emerging pneumonia-like illness “legionellosis” in Argentina in the COVID-19 era: Cause to panic?

The effect of Nigella sativa and vitamin D3 supplementation on the clinical outcome in COVID-19 patients: A randomized controlled clinical trial

Nanodelivery of antiretroviral drugs to nervous tissues

The recommended dosage regimen for caspofungin in patients with higher body weight or hypoalbuminaemia will result in low exposure: Five years of data based on a population pharmacokinetic model and Monte-Carlo simulations

Synthetic approaches to potent heterocyclic inhibitors of tuberculosis: A decade review

Berberine prevents lethal EV71 neurological infection in newborn mice

Polyphenolic promiscuity, inflammation-coupled selectivity: Whether PAINs filters mask an antiviral asset

Genotype-phenotype association and biochemical analyses of glucose-6-phosphate dehydrogenase variants: Implications for the hemolytic risk of using 8-aminoquinolines for radical cure

Minocycline intra-bacterial pharmacokinetic hysteresis as a basis for pharmacologic memory and a backbone for once-a-week pan-tuberculosis therapy

Safety and effectiveness of all-oral and injectable-containing, bedaquiline-based long treatment regimen for pre-XDR tuberculosis in Vietnam

Antimicrobial and anti-inflammatory effects of Eugenia brejoensis essential oil in mice wounds infected by Staphylococcus aureus

Terpenes as bacterial efflux pump inhibitors: A systematic review

The OBTAINS study: A nationwide cross-sectional survey on the implementation of extended or continuous infusion of β-lactams and vancomycin among neonatal sepsis patients in China

Effects of CYP2C19 genetic polymorphisms on the cure rates of H. pylori in patients treated with the proton pump inhibitors: An updated meta-analysis

Editorial: Women in pharmacology of infectious diseases: 2021